α- and β-secretase:: profound changes in Alzheimer's disease

被引:152
|
作者
Tyler, SJ
Dawbarn, D
Wilcock, GK
Allen, SJ [1 ]
机构
[1] Univ Bristol, Bristol Royal Infirm, Mol Neurobiol Unit, URCN Care Elderly, Bristol BS2 8HW, Avon, England
[2] Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England
关键词
Alzheimer's disease; alpha-secretase; amyloid; apolipoprotein E; beta-secretase; BACE; choline acetyltransferase; TACE;
D O I
10.1016/S0006-291X(02)02635-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid plaque, a neuropathological hallmark of Alzheimer's disease, is produced by the deposition of beta-amyloid (Abeta) peptide, which is cleaved from Amyloid Precursor Protein (APP) by the enzyme beta-secretase. Only small amounts of Abeta form in normal brain; more typically this is precluded by the processing of APP by alpha-secretase. Here, we describe a decrease in alpha-secretase (81% of normal) and a large increase in beta-secretase activity (185%) in sporadic Alzheimer's disease temporal cortex. Since alpha-secretase is present principally in neurons known to be vulnerable in Alzheimer's disease, and there is known competition between alpha- and beta-secretase for the substrate APP, it is significant that the majority of Alzheimer samples tested here were low in a-secretase. Eighty percent of Alzheimer brains examined had an increase in beta-secretase, a decrease in alpha-secretase, or both; which may account for the means by which the majority of people develop Alzheimer's disease. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [31] β-secretase as a therapeutic target for Alzheimer's disease
    Ghosh, Arun K.
    Gemma, Sandra
    Tang, Jordan
    NEUROTHERAPEUTICS, 2008, 5 (03) : 399 - 408
  • [32] Dysfunctional γ-Secretase in Familial Alzheimer’s Disease
    Michael S. Wolfe
    Neurochemical Research, 2019, 44 : 5 - 11
  • [33] Targeting γ-secretase for familial Alzheimer's disease
    Wolfe, Michael S.
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (07) : 1321 - 1327
  • [34] γ-secretase as a therapeutic target for the treatment of Alzheimer's disease
    Churcher, I
    Beher, D
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (26) : 3363 - 3382
  • [35] Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease
    Olson, Richard E.
    Marcin, Lawrence R.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 : 27 - 47
  • [36] A promising new γ-secretase modulator for Alzheimer's disease
    Zakaria, Justyna A. Dobrowolska
    Vassar, Robert J.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (04):
  • [37] Presenilins and "gamina-secretase" in Alzheimer's disease
    Sisodia, SS
    Kim, SH
    Ikeuchi, T
    Yu, CJ
    Thinakaran, G
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 400A - 400A
  • [38] Selective Secretase Targeting for Alzheimer's Disease Therapy
    Miranda, Alvaro
    Montiel, Enrique
    Ulrich, Henning
    Paz, Cristian
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 81 (01) : 1 - 17
  • [39] Prospects of -Secretase Inhibitors for the Treatment of Alzheimer's Disease
    Ghosh, Arun K.
    Tang, Jordan
    CHEMMEDCHEM, 2015, 10 (09) : 1463 - 1466
  • [40] Turning the tide on Alzheimer’s disease: modulation of γ-secretase
    Joanna E. Luo
    Yue-Ming Li
    Cell & Bioscience, 12